AdminJun 13, 20213 minLandos Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for Omilancor https://www.globenewswire.com/news-release/2021/06/14/2246385/0/en/Landos-Biopharma-Announces-Positive-Outcome-of-End-of-Phase-2-Meeting-...
AdminJun 13, 20212 minTotient, a Helicase Venture Portfolio Company, has been Acquired by AbSciTotient, a Helicase Venture portfolio company, has been acquired by AbSci, a synthetic biology company unlocking the potential of...
AdminMay 16, 20213 minLandos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets BLACKSBURG, Va., and SHANGHAI, China and PRINCETON, N.J., May 17, 2021 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc (NASDAQ: LABP), a...